newsfilter
← Latest News
Business Wire·

Cortexyme Appoints Dr. Philip Low to Its Board of Directors

Cortexyme, Inc. (NASDAQ:CRTX), a clinical-stage biopharmaceutical company pioneering therapeutic approaches to improve the lives of patients diagnosed with degenerative diseases, today announced the appointment of Dr. Philip S. Low, a renowned targeted